Yhn HealthHealth first seen 2 d ago, last 40 min ago, peak #1

Moderna and Merck mRNA cancer vaccine cuts death, recurrence 42%

Original: Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

Moderna and Merck report that their personalized mRNA cancer vaccine, developed for melanoma, reduced risk of death and cancer recurrence by 42% compared with standard treatment alone. The news is drawing wide attention as one of the clearest signs yet that mRNA technology, proven in COVID-19 vaccines, could transform cancer treatment.

Why now: A major clinical success for mRNA cancer therapy has significant implications for the future of cancer treatment.

ModernaMerckmelanomamRNA cancer vaccine

Open on hn →

Rank over time, top of the chart is #1. 11 snapshots from 5 h ago to 40 min ago.

Evidence

• Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42% · _Microft · 205
• Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42% · nathcd · 6

API: https://socialmediatrends-api.osmike.com/v1/trends/3528419